AI for Pharma & Healthcare 2025

Industry Updates

AI-Pathway Companion Prostate Cancer from Siemens Healthineers approved...

AI-Pathway Companion Prostate Cancer, a digital companion from Siemens Healthineers to support clinical decision-making, has recently received the CE mark for use in the clinical...

Nexelis to Acquire Specialty Immunogenicity and Immune-Oncology Testing...

Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of assay development and advanced laboratory testing is pleased to announce the signing...

American Oncology Network Continues Strategic Relationship with AmerisourceBergen

global healthcare solutions leader AmerisourceBergen announced that it is continuing its strategic relationship with the American Oncology Network, LLC (AON), a high-growth medical oncology provider...

V-Wave Receives CE Mark for the Ventura Interatrial...

CE Mark for the Venturaâ„¢ Interatrial Shunt System is a significant milestone for V-Wave, as it recognizes that this therapeutic product conforms to the standards...

Syndigo Introduces Comprehensive Global UDI Solution for Medical...

Syndigo, a leading provider of verified product content syndication services, announced the addition of Unique Device Identifier (UDI) compliant product information for medical device manufacturers,...

SAM Medical Launches New SAM IO Intraosseous Access...

SAM Medical, an industry leader committed to developing and manufacturing the most innovative trauma care medical devices, announced the launch of the SAM IO Intraosseous...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »